Rett syndrome (RTT) is a severe progressive neurological disorder that affe
cts almost exclusively females, with an estimated prevalence of approximate
ly one in 10 000-15 000 female births. Most cases are sporadic, but several
reports about familial recurrence support X-linked dominant inheritance wi
th male lethality. The gene responsible for this disorder, MECP2, was recen
tly identified by candidate gene strategy. Mutations were detected in <25%
of RTT cases in this first report. To characterize the spectrum of mutation
s in the MECP2 gene in RTT patients, we selected 46 typical RTT patients an
d performed mutation screening by denaturing gradient gel electrophoresis c
ombined with direct sequencing. We identified 30 mutations, accounting for
65% of RTT patients. They include 12 novel mutations (11 located in exon 3
and one in exon 2). Mutations, such as R270X and frameshift deletions in a
(CCACC)(n) rich region, have been found with multiple recurrences. Most of
the mutations were de nova, except in one family where the non-affected tra
nsmitter mother exhibited a bias of X inactivation. Although this study sho
wed that MECP2 mutations account for most cases of typical forms of RTT (65
%) and mutations in non-coding regions cannot be excluded for the remaining
cases, an alternative hypothesis that takes into account the homogeneous p
henotype and exclusive involvement of females, could be the implication in
RTT of a putative second X-linked gene.